La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Inpixon Bilan de santé

Santé financière contrôle des critères 5/6

Inpixon possède un total de capitaux propres de $7.9M et une dette totale de $11.2M, ce qui porte son ratio d'endettement à 141.7%. Son actif total et son passif total sont $27.6M et de $19.8M.

Informations clés

141.7%

Ratio d'endettement

US$11.17m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	US$13.49m
Fonds propres	US$7.88m
Total du passif	US$19.77m
Total des actifs	US$27.65m

Mises à jour récentes de la santé financière

Is Inpixon (NASDAQ:INPX) Using Debt In A Risky Way?

Oct 09

Recent updates

Even With A 179% Surge, Cautious Investors Are Not Rewarding Inpixon's (NASDAQ:INPX) Performance Completely

Apr 17

Examining The Sysorex, Inpixon, And TTM Digital Assets Reverse Triangular Merger For Opportunities

Jun 01

Inpixon buys SaaS app platform

May 03

Inpixon acquires AR, computer vision and 3D reconstruction technologies from Visualix

Apr 26

Inpixon prices $10M registered direct offering

Nov 27

Inpixon's mapping platform chosen by pharmaceutical company to facilitate tracking of COVID-19 vaccine-related assets, shares up 7%

Nov 18

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de INPX ( $22.6M ) dépassent ses passifs à court terme ( $19.6M ).

Passif à long terme: Les actifs à court terme de INPX ( $22.6M ) dépassent ses passifs à long terme ( $188.0K ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: INPX dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de INPX est passé de 21.7% à 141.7% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: INPX dispose d'une piste de trésorerie suffisante pour 5 mois sur la base du dernier flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Prévisions de trésorerie: INPX devrait disposer d'une marge de trésorerie suffisante pour 5 mois sur la base des estimations de flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Inpixon Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Inpixon announced delayed 10-Q filing

Inpixon announced delayed 10-Q filing

Inpixon announced delayed 10-Q filing

Inpixon Reports Compliance with Nasdaq's Listing Requirement

Is Inpixon (NASDAQ:INPX) Using Debt In A Risky Way?

Recent updates

Inpixon has withdrawn its Follow-on Equity Offering in the amount of $10 million.

Inpixon has withdrawn its Follow-on Equity Offering in the amount of $10 million.

Inpixon(NasdaqCM:INPX) dropped from NASDAQ Composite Index

Inpixon has filed a Follow-on Equity Offering in the amount of $10 million.

Inpixon announced delayed 10-Q filing

Insufficient new directors

Inpixon to Report Q3, 2023 Results on Nov 14, 2023

Inpixon announced delayed 10-Q filing

Insufficient new directors

Inpixon to Report Q2, 2023 Results on Aug 14, 2023

XTI Aircraft Company entered into a definitive merger agreement to acquire Inpixon (NasdaqCM:INPX) in a reverse merger transaction.

XTI Aircraft Company entered into a definitive merger agreement to acquire Inpixon (NasdaqCM:INPX) in a reverse merger transaction.

Inpixon announced delayed 10-Q filing

First quarter 2023 earnings released: US$0.98 loss per share (vs US$9.40 loss in 1Q 2022)

Inpixon to Report Q1, 2023 Results on May 15, 2023

Even With A 179% Surge, Cautious Investors Are Not Rewarding Inpixon's (NASDAQ:INPX) Performance Completely

Full year 2022 earnings released: US$27.18 loss per share (vs US$53.70 loss in FY 2021)

Third quarter 2022 earnings released: US$11.35 loss per share (vs US$21.43 loss in 3Q 2021)

Insufficient new directors

Inpixon to Report Q3, 2022 Results on Nov 14, 2022

Inpixon Reports Compliance with Nasdaq's Listing Requirement

Inpixon, Annual General Meeting, Nov 28, 2022

Inpixon stock slides after pricing $15M securities offering

Is Inpixon (NASDAQ:INPX) Using Debt In A Risky Way?

Inpixon Achieves FCC, ISED Certifications and Establishes CE Status for Inpixon Swarm Chirp V3

Second quarter 2022 earnings released: US$0.097 loss per share (vs US$0.13 profit in 2Q 2021)

Inpixon Non-GAAP EPS of -$0.07, revenue of $4.73M

Inpixon to Report Q2, 2022 Results on Aug 15, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Inpixon to Report Q1, 2022 Results on May 16, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Inpixon Brings UWB and Chirp RTLS to Award-Winning Inpixon Aware

Inpixon Secures Broad Patent Protection for Use of Sensor Fusion to Determine Location

Inpixon Launches Active Tag for Long-Range, Real-Time Location System (RTLS) Asset Tracking

Inpixon wins multi-year contract for smart office app

Examining The Sysorex, Inpixon, And TTM Digital Assets Reverse Triangular Merger For Opportunities

Inpixon (NasdaqCM:INPX) acquired Design Reactor, Inc. from Leon Papkoff.

Inpixon buys SaaS app platform

Inpixon acquires AR, computer vision and 3D reconstruction technologies from Visualix

Inpixon to Report Fiscal Year 2020 Results on Mar 25, 2021

Inpixon to Provide Co2 Sensors to Help Identify COVID-19 Infection Risk

Inpixon Launches Next-Generation RTLS Anchor for Integrators and OEMs

Inpixon Releases Enhanced Inpixon Aware Security Solution

Inpixon Enters Contract for Nearly One Million Square Feet of Mapping

Inpixon Releases High-Performance, Real-Time Location System Server Enhancements

Inpixon Enhances Enterprise-Class and Social Distancing Features with New Inpixon Mapping Release

Inpixon prices $10M registered direct offering

Leading Pharmaceutical Corporation Selects Inpixon Mapping to Facilitate Tracking of COVID-19 Vaccine-Related Assets

Inpixon's mapping platform chosen by pharmaceutical company to facilitate tracking of COVID-19 vaccine-related assets, shares up 7%

Inpixon Announces Availability of Location Intelligence Products Through Global Distributor Digi-Key

Inpixon to Report Q3, 2020 Results on Nov 12, 2020

Inpixon Launches Advanced RTLS Tag Module for Real-Time Positioning

Sysorex Global Holdings Corp. (OTCPK:SYRX) completed the acquisition of AirPatrol Corporation for $29.3 million.

Inpixon to Report Q2, 2020 Results on Aug 13, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines